The Guardian: Malaria in Mozambique: trialing payment by results
Lily Han, investment principal with Dalberg Global Development Advisers, a private sector partner working to launch the Mozambique Malaria performance bond

“Malaria control programs in recent decades offer overwhelming evidence that integrated, sustained malaria-eradication protocols that cover prevention, diagnosis, and treatment achieve results. But two factors have kept the disease burden posed by malaria high in some of the most underdeveloped parts of the world: a lack of sustained financing and lack of coordination among interventions. This is exactly why malaria is such a prime target for applying development impact bonds (DIBs), a new way of attracting funding for development issues such as malaria…” (3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.